ACRVVSBTAI• 12 Months (Normalized)
ACRV vs BTAI (Acrivon Therapeutics Inc. vs BioXcel Therapeutics Inc.)
Showing Closing Date Range from Sep, 18, 2025 to Sep, 18, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ACRV Performance $1.85
+10.48%
Acrivon Therapeutics Inc.
Normalized Baseline0.00%
BTAI Performance $0.08
+%
BioXcel Therapeutics Inc.
Normalized Baseline0.00%
Alpha Spread Margin ACRV LEADS
+10.48%
ACRV outperforming by 10.48%
ACRVBTAI
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ACRV BTAI
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(252 dates)
| Date | ACRV Price | ACRV Gain (%) | BTAI Price | BTAI Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 18, 2026 | $1.85 | +10.48% | $- | - | |
| Sep 17, 2026 | $1.70 | +1.80% | $0.08 | -97.50% | +99.30% |
| Sep 16, 2026 | $1.70 | +1.80% | $0.07 | -97.78% | +99.58% |
| Sep 15, 2026 | $1.83 | +9.58% | $0.04 | -98.51% | +108.09% |
| Sep 14, 2026 | $1.96 | +17.37% | $0.05 | -98.50% | +115.87% |
| Sep 11, 2026 | $2.00 | +19.76% | $0.05 | -98.31% | +118.07% |
| Sep 10, 2026 | $2.04 | +22.16% | $0.05 | -98.34% | +120.50% |
| Sep 09, 2026 | $1.99 | +19.16% | $0.05 | -98.44% | +117.60% |
| Sep 08, 2026 | $2.10 | +25.75% | $0.04 | -98.57% | +124.32% |
| Sep 04, 2026 | $2.13 | +27.54% | $0.07 | -97.54% | +125.08% |
| Sep 03, 2026 | $2.06 | +23.35% | $0.12 | -96.08% | +119.43% |
| Sep 02, 2026 | $2.15 | +28.74% | $0.11 | -96.45% | +125.19% |
| Sep 01, 2026 | $2.07 | +23.95% | $0.14 | -95.45% | +119.40% |
| Aug 31, 2026 | $2.09 | +25.15% | $0.16 | -94.58% | +119.73% |
| Aug 28, 2026 | $2.06 | +23.35% | $0.18 | -93.99% | +117.34% |
Page 1 of 17